Home
Long Focus Capital Management reported a 0% stake in ADS shares of Adaptimmune Therapeutics ADAPY · 0 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 0%
- Last report
- 8% · filed 25/02/11
- Shares held
- 0 sh
- Class
- American Depositary Shares, each representing 6 Ordinary Shares
- Event date
- 25/12/31
- Filed
- 26/02/17
0% stake · fully exited
- Stake
- 0%
- Last report
- 8%
- Since last report
- −8.0pp
Adaptimmune Therapeutics trades, last 26 weeks
What else happened in Adaptimmune Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Long Focus Capital Management's other 5% stake reports
- Long Focus Capital Management
5% stakeStandard Biotools
5% stakeStandard Biotools
LAB
6% stake
23,500,000 sh
6% stake
Filed 08/14
- Long Focus Capital Management
5% stakeAura Biosciences
5% stakeAura Biosciences
AURA
4.9% stake
5,119,582 sh
4.9% stake
Filed 08/14
- Long Focus Capital Management
5% stakeOnity Group
5% stakeOnity Group
ONIT
6.3% stake
540,598 sh
6.3% stake
Filed 05/15
- Long Focus Capital Management
5% stakeTilly's
5% stakeTilly's
TLYS
0% stake
0 sh
0% stake
Filed 05/15
- Long Focus Capital Management
5% stakeBicycle Therapeutics
5% stakeBicycle Therapeutics
BCYC
6.6% stake
3,310,687 sh
6.6% stake
Filed 05/15
